Active Ingredient: Mexazolam
Mexazolam is indicated for the management of anxiety disorder associated or not to psychoneurotic conditions.
Benzodiazepines are only indicated when the disorder is severe, disabling or subjecting the individual to extreme distress.
For this indication, competent medicine agencies globally authorize below treatments:
For:
Oral, between 1 milligrams mexazolam and 3 milligrams mexazolam, divided daily, 1 to 3 doses in total, over the duration of 8 to 12 weeks.
Dosage should be individualised according to the severity of symptoms.
Average dose is 1–3 mg daily, preferably divided in three doses.
Treatment of anxiety should be as short as possible. The patient should be reassessed regularly and the need for continued treatment should be evaluated, especially in case the patient is symptom free.
The overall duration of treatment generally should not be more than 8-12 weeks including the tapering off process. In certain cases extension beyond the maximum treatment period may be necessary; if so, it should not take place without revaluation of the patient’s status with special expertise.
In any case treatment should be started with the lowest recommended dose.
In case of a missing dose after more than 1 hour as scheduled do not take it. Do not double the dose.
The patient should be checked regularly observed at the start of the treatment in order to decrease if necessary, the dose or frequency of administration to prevent overdose due to accumulation.
For:
Oral, between 1 milligrams mexazolam and 1.5 milligrams mexazolam, divided daily, 1 to 3 doses in total, over the duration of 8 to 12 weeks. The maximum allowed total dose is 1.5 milligrams mexazolam daily.
Dosage should be individualised according to the severity of symptoms.
Do not exceed 1,5 mg daily.
Treatment of anxiety should be as short as possible. The patient should be reassessed regularly and the need for continued treatment should be evaluated, especially in case the patient is symptom free.
The overall duration of treatment generally should not be more than 8-12 weeks including the tapering off process. In certain cases extension beyond the maximum treatment period may be necessary; if so, it should not take place without revaluation of the patient’s status with special expertise.
In any case treatment should be started with the lowest recommended dose.
In case of a missing dose after more than 1 hour as scheduled do not take it. Do not double the dose.
The patient should be checked regularly observed at the start of the treatment in order to decrease if necessary, the dose or frequency of administration to prevent overdose due to accumulation.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
